Outcomes of Ahmed Valve Implant Following a Failed Initial Trabeculotomy and Trabeculectomy in Refractory Primary Congenital Glaucoma
| العنوان: | Outcomes of Ahmed Valve Implant Following a Failed Initial Trabeculotomy and Trabeculectomy in Refractory Primary Congenital Glaucoma |
|---|---|
| المؤلفون: | Sirisha Senthil, Nikhil S. Choudhari, Paaraj Dave, G C Sekhar |
| المصدر: | Middle East African Journal of Ophthalmology |
| بيانات النشر: | Medknow Publications & Media Pvt Ltd, 2015. |
| سنة النشر: | 2015 |
| مصطلحات موضوعية: | Male, medicine.medical_specialty, Intraocular pressure, genetic structures, medicine.medical_treatment, Visual Acuity, Trab, Trabeculectomy, Glaucoma valve, Prosthesis Implantation, Tonometry, Ocular, Refractory, Ophthalmology, medicine, Glaucoma surgery, Failed Trabeculotomy and Trabeculectomy, Humans, Treatment Failure, Ahmed Valve Implant, Glaucoma Drainage Implants, Intraocular Pressure, Retrospective Studies, business.industry, Hydrophthalmos, Infant, General Medicine, Trabeculotomy, eye diseases, Surgery, Treatment Outcome, Refractory Congenital Glaucoma, Original Article, Female, Implant, sense organs, business, Follow-Up Studies |
| الوصف: | Purpose: The aim was to report the outcome of Ahmed glaucoma valve (AGV) (New World Medical, Inc., Rancho Cucamonga, CA, USA) implantation as a surgical intervention following an initial failed combined trabeculotomy + trabeculectomy (trab + trab) in refractory primary congenital glaucoma (RPCG). Materials and Methods: Retrospective chart review of 11 eyes of 8 patients who underwent implantation of AGV (model FP8) for RPCG between 2009 and 2011. Prior trab + trab had failed in all the eyes. Success was defined as an intraocular pressure (IOP) >5 and ≤ 18 mmHg during examination under anesthesia with or without medications and without serious complications or additional glaucoma surgery. Results: The mean age at AGV implantation was 15.4 ± 4.9 months. The mean preoperative IOP was 28 ± 5.7 mmHg which reduced to 13.6 ± 3.4 mmHg postoperatively at the last follow-up (P < 0.0001). The number of topical antiglaucoma medications reduced from a mean of 2.6 ± 0.5 to 1.6 ± 0.9 postoperatively (P = 0.009). The definition of qualified success was met in 10 (90%) eyes. One eye developed a shallow anterior chamber with choroidal detachment at 1-week, which resolved spontaneously with medications. None of the eyes developed a hypertensive phase. One eye had a long tube resulting in tube corneal touch that required trimming of the tube. One eye developed tube retraction, which was treated with a tube extender. The mean follow-up was 17.9 ± 9.3 (6.2-35.4) months. Conclusion: Managing RPCG remains a challenge. AGV implant was successful in a significant proportion of cases. |
| اللغة: | English |
| تدمد: | 0975-1599 0974-9233 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da169f3d4ae3a18125865a8d67157096 http://europepmc.org/articles/PMC4302479 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....da169f3d4ae3a18125865a8d67157096 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 09751599 09749233 |
|---|